PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY: Form 990, tax year 2019

View the entire original 990 at ProPublica ↗

Organization
PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY (EIN 47-3355381)
Tax period
2019-01-01 to 2019-12-31
Filed
2020-11-16
IRS object ID
202043219349313849
Schema version
2019v5.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2020-11-16T14:20:51-06:00ReturnTs
Tax Period End2019-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN910189318PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1MOSS ADAMS LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line14747 EXECUTIVE DRIVE SUITE 1300AddressLine1Txt
CitySAN DIEGOCityNm
State AbbreviationCAStateAbbreviationCd
ZIP92121ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2019-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN473355381EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1PARKER INSTITUTE FOR CANCERBusinessNameLine1Txt
Business Name Line2IMMUNOTHERAPYBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlPARKBusinessNameControlTxt
Phone4159304386PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11 LETTERMAN DRIVE D3500AddressLine1Txt
CitySAN FRANCISCOCityNm
State AbbreviationCAStateAbbreviationCd
ZIP94129ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonMICHAEL POLANSKYPersonNm
Person TitleEXEC. VPPersonTitleTxt
Phone4159304386PhoneNum
Signature2020-11-14SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonPATRICIA J MAYERPreparerPersonNm
PTINP00188643PTIN
Phone8586271400PhoneNum
FieldValueIRS element (for citing)
Tax2019TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerFREDERIC PLAPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line11 LETTERMAN DRIVE D3500AddressLine1Txt
CitySAN FRANCISCOCityNm
State AbbreviationCAStateAbbreviationCd
ZIP94129ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$212,741,433GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.PARKERICI.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2015FormationYr
Legal Domicile StateCALegalDomicileStateCd
Activity Or MissionTHE PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY (PICI) WAS CREATED TO ENCOURAGE ADVANCES IN CANCER IMMUNOTHERAPY RESEARCH AND TO HELP REDUCE OBSTACLES TO COLLABORATION, DISCOVERY AND TRANSLATION OF THESE ADVANCES FOR PATIENTS. PICI ACHIEVES THIS GOAL BY FUNDING A CONSORTIUM OF PREEMINENT ACADEMIC AND MEDICAL RESEARCH INSTITUTIONS WHICH WORK COLLABORATIVELY ON RESEARCH IN THE FIELD OF CANCER IMMUNOTHERAPY. IN ADDITION, PICI FURTHERS ITS CHARITABLE PURPOSES BY EMPLOYING ITS OWN PERSONNEL TO DIRECTLY CONDUCT RESEARCH AND CLINICAL TRIALS.ActivityOrMissionDesc
Voting Members Governing Body15VotingMembersGoverningBodyCnt
Voting Members Independent14VotingMembersIndependentCnt
Total Employee88TotalEmployeeCnt
Total Volunteers13TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$110,149,251PYContributionsGrantsAmt
CY Contributions Grants$146,644,584CYContributionsGrantsAmt
PY Program Service Revenue$3,019,898PYProgramServiceRevenueAmt
CY Program Service Revenue$15,232,654CYProgramServiceRevenueAmt
PY Investment Income$270,002PYInvestmentIncomeAmt
CY Investment Income$771,326CYInvestmentIncomeAmt
PY Other Revenue$0PYOtherRevenueAmt
CY Other Revenue$0CYOtherRevenueAmt
PY Total Revenue$113,439,151PYTotalRevenueAmt
CY Total Revenue$162,648,564CYTotalRevenueAmt
PY Grants And Similar Paid$34,959,862PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$34,963,492CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$16,056,809PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$17,612,141CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$200,000CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$200,000CYTotalFundraisingExpenseAmt
PY Other Expenses$15,185,495PYOtherExpensesAmt
CY Other Expenses$25,188,982CYOtherExpensesAmt
PY Total Expenses$66,202,166PYTotalExpensesAmt
CY Total Expenses$77,964,615CYTotalExpensesAmt
PY Revenues Less Expenses$47,236,985PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$84,683,949CYRevenuesLessExpensesAmt
Total Assets BOY$68,405,361TotalAssetsBOYAmt
Total Assets EOY$159,252,481TotalAssetsEOYAmt
Total Liabilities BOY$4,490,244TotalLiabilitiesBOYAmt
Total Liabilities EOY$10,653,415TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$63,915,117NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$148,599,066NetAssetsOrFundBalancesEOYAmt
MissionTO ACCELERATE THE DEVELOPMENT OF BREAKTHROUGH IMMUNOTHERAPIES TO TURN ALL CANCERS INTO CURABLE DISEASES BY SUPPORTING AND ACTIVELY ENGAGING IN THE CONDUCT OF MEDICAL RESEARCH IN CONJUNCTION WITH ITS CONSORTIUM OF PREEMINENT HOSPITALS AND ACADEMIC RESEARCH CENTERS.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$66,958,050ExpenseAmt
Grant$34,963,492GrantAmt
Revenue$15,232,654RevenueAmt
DescPICI ENCOURAGES ADVANCES IN CANCER IMMUNOTHERAPY RESEARCH, COLLABORATION, AND DISCOVERY, AND THE TRANSLATION OF THESE ADVANCES INTO CURES AND TREATMENTS FOR THE BENEFIT OF PATIENTS. TO DO THIS, PICI CONDUCTS ITS OWN RESEARCH AND CLINICAL TRIALS AND PROVIDES ITS CONSORTIUM OF PREEMINENT HOSPITALS AND ACADEMIC RESEARCH CENTERS WITH SHARED RESEARCH RESOURCES, SUCH AS SCIENTIFIC EQUIPMENT, CONSUMABLES, BIOINFORMATICS ANALYSIS, AND A SPECIMEN BIOBANK. PICI ALSO FUNDS AND OTHERWISE SUPPORTS CANCER IMMUNOTHERAPY RESEARCH WITHIN ITS CONSORTIUM.Desc
Total Program Service Expenses$66,958,050TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related InvstYes (1)ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other Liabilities0ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (1)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (1)IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign Activities0ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional FundraisingYes (1)ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan OutstandingYes (1)LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document47IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee88EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members15GoverningBodyVotingMembersCnt
Independent Voting Member14IndependentVotingMemberCnt
Family Or Business RlnYes (1)FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org DocumentsYes (1)ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board MembersYes (1)ElectionOfBoardMembersInd
Decisions Subject To ApprovaYes (1)DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1PARKER INSTITUTE FOR CANCER IMMUNOTHERAPYBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone4159857311PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line11 LETTERMAN DRIVE SUITE D3500AddressLine1Txt
CitySAN FRANCISCOCityNm
State AbbreviationCAStateAbbreviationCd
ZIP94129ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (23 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtKey EmployeeKeyEmployeeIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
RAMY IBRAHIM
CHIEF MEDICAL OFFICER40.00Yes (X)$884,132$0$25,988
JEFFREY A BLUESTONE PHD
PRESIDENT/CEO & DIRECTOR40.00$709,428$0$23,895Yes (X)Yes (X)
FREDERICK J RAMSDELL
CHIEF SCIENTIFIC OFFICER (THRU 12/19)40.00$432,060$0$26,223Yes (X)
THERESA LAVALLEE
VP-TRANSLATIONAL MEDICINE40.00$416,755$0$34,480Yes (X)
NIKESH KOTECHA
VP-INFORMATICS40.00$417,850$0$20,797Yes (X)
MELINDA GRIFFITH
CHIEF LEGAL COUNSEL, VP-ST40.00$409,259$0$20,452Yes (X)
SUSAN SCHULTZ
VP-BUSINESS OPERATIONS40.00Yes (X)$377,457$0$32,074
CHERYL SELINSKY PHD
VP-RESEARCH OPERATIONS40.00$379,251$0$13,254Yes (X)
SEAN N PARKER
CHAIR OF THE BOARD & DIRECTOR1.00$0$0$0Yes (X)Yes (X)
MICHAEL POLANSKY
EXECUTIVE VP & DIRECTOR1.00$0$0$0Yes (X)Yes (X)
TOM VAN LOBEN SELS
SECRETARY/TREASURER & DIRECTOR1.00$0$0$0Yes (X)Yes (X)
TONY COLES
DIRECTOR1.00$0$0$0Yes (X)
ERIC ESRAILIAN MD MPH
DIRECTOR1.00$0$0$0Yes (X)
SCOTT GOTTLIEB MD
DIRECTOR1.00$0$0$0Yes (X)
BEN HOROWITZ
DIRECTOR1.00$0$0$0Yes (X)
JEFF HUBER
DIRECTOR1.00$0$0$0Yes (X)
BOB HUGIN
DIRECTOR1.00$0$0$0Yes (X)
REED JOBS
DIRECTOR1.00$0$0$0Yes (X)
JOEL MARCUS
DIRECTOR1.00$0$0$0Yes (X)
BOB NELSEN
DIRECTOR1.00$0$0$0Yes (X)
BRUCE PARKER
DIRECTOR1.00$0$0$0Yes (X)
BOB PITTMAN
DIRECTOR1.00$0$0$0Yes (X)
SUSAN DAWSON
SECRETARY1.00$0$0$0Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$4,026,192TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$197,163TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K56IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
PRECISION CANCER RESEARCH
17607 GOLD PLAZAOMAHANE68130BIOSTORAGE AND SAMPLE PROCESSING$1,562,828
ARIS CLINICAL INC
369-B THIRD STREET 231SAN RAFAELCA94901CLINICAL TRIAL MONITORING$1,340,873
GREENPHIRE
1018 W 9TH AVE SUITE 200KING OF PRUSSIAPA19406CLINICAL TRIAL PAYMENT PROCESSING$1,074,374
BIOSTORAGE TECHNOLOGIES INC
2910 FORTUNE CIRCLE W EINDIN46241BIOSTORAGE AND SAMPLE PROCESSING$972,929
CLINLOGIX
8 SPRING HOUSE INNOVATION PARKLOWER GWYNEDDPA190022793CLINICAL TRIAL MONITORING$726,294
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K39CntrctRcvdGreaterThan100KCnt
All Other Contributions$146,644,584AllOtherContributionsAmt
Noncash Contributions$50,092,869NoncashContributionsAmt
Total Contributions$146,644,584TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (2 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt
RESEARCH STUDY SPONSORSHIP900099$10,232,654$10,232,654
PROGRAM-RELATED LOAN INCOME900099$5,000,000$5,000,000
FieldValueIRS element (for citing)
Total Program Service Revenue$15,232,654TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$771,326TotalRevenueColumnAmt
Exclusion$771,326ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$50,092,869SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$50,092,869SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$0SecuritiesAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$162,648,564TotalRevenueColumnAmt
Related Or Exempt Func Income$15,232,654RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$771,326ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$34,963,492TotalAmt
Program Services$34,963,492ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$2,052,973TotalAmt
Program Services$1,480,018ProgramServicesAmt
Management And General$572,955ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$13,105,701TotalAmt
Program Services$9,456,927ProgramServicesAmt
Management And General$3,648,774ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$288,800TotalAmt
Program Services$203,518ProgramServicesAmt
Management And General$85,282ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$1,343,463TotalAmt
Program Services$946,742ProgramServicesAmt
Management And General$396,721ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$821,204TotalAmt
Program Services$594,540ProgramServicesAmt
Management And General$226,664ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$1,243,380TotalAmt
Program Services$1,138,430ProgramServicesAmt
Management And General$104,950ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$92,327TotalAmt
Program Services$36,931ProgramServicesAmt
Management And General$55,396ManagementAndGeneralAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$200,000TotalAmt
Fundraising$200,000FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$6,502,118TotalAmt
Program Services$4,892,194ProgramServicesAmt
Management And General$1,609,924ManagementAndGeneralAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$70,695TotalAmt
Program Services$38,122ProgramServicesAmt
Management And General$32,573ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$3,143,818TotalAmt
Program Services$3,054,916ProgramServicesAmt
Management And General$88,902ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$718,268TotalAmt
Program Services$451,134ProgramServicesAmt
Management And General$267,134ManagementAndGeneralAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$1,350,847TotalAmt
Program Services$540,339ProgramServicesAmt
Management And General$810,508ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$456,032TotalAmt
Program Services$373,545ProgramServicesAmt
Management And General$82,487ManagementAndGeneralAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$2,022,633TotalAmt
Program Services$1,035,841ProgramServicesAmt
Management And General$986,792ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$1,911,495TotalAmt
Program Services$764,598ProgramServicesAmt
Management And General$1,146,897ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$261,608TotalAmt
Program Services$104,643ProgramServicesAmt
Management And General$156,965ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmt
SUPPLIES AND TESTING$5,365,853$5,228,784$137,069
EQUIPMENT/SOFTWARE$910,889$868,356$42,533
RECRUITING$484,396$209,998$274,398
DUES & MEMBERSHIPS$91,607$49,564$42,043

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$563,016TotalAmt
Program Services$525,418ProgramServicesAmt
Management And General$37,598ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$77,964,615TotalAmt
Program Services$66,958,050ProgramServicesAmt
Management And General$10,806,565ManagementAndGeneralAmt
Fundraising$200,000FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$5,414,164BOYAmt
EOY$13,206,800EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$6,563,995BOYAmt
EOY$60,821,581EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$342,167BOYAmt
EOY$150,091EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$420,000BOYAmt
EOY$280,000EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$602,805BOYAmt
EOY$699,005EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$7,940,787LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$3,498,975LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$3,235,614BOYAmt
EOY$4,441,812EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
EOY$2,000,000EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$51,499,999BOYAmt
EOY$77,326,575EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$326,617BOYAmt
EOY$326,617EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$68,405,361BOYAmt
EOY$159,252,481EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$4,490,244BOYAmt
EOY$10,653,415EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$4,490,244BOYAmt
EOY$10,653,415EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$63,588,500BOYAmt
EOY$148,272,449EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$326,617BOYAmt
EOY$326,617EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$63,915,117BOYAmt
EOY$148,599,066EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$68,405,361BOYAmt
EOY$159,252,481EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$84,683,949ReconcilationRevenueExpnssAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit Required0FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Medical Research OrganizationYes (X)MedicalResearchOrganizationInd

Hospital Name And Address HospitalNameAndAddressGrp (7 entries)

CityCityNmState AbbreviationStateAbbreviationCd
MEMORIAL SLOAN KETTERING CANCER CENTER
NEW YORKNY
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
HOUSTONTX
STANFORD MEDICINE
STANFORDCA
UNIVERSITY OF CALIFORNIA LOS ANGELES
LOS ANGELESCA
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
SAN FRANCISCOCA
UNIVERSITY OF PENNSYLVANIA
PHILADELPHIAPA
DANA-FARBER CANCER INSTITUTE
BOSTONMA

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE A SUPPLEMENTAL INFORMATION:FormAndLineReferenceDesc
ExplanationPICI IS A MEDICAL RESEARCH ORGANIZATION FOR ITS TAXABLE YEAR ENDED DECEMBER 31, 2019, AS ITS EXPENDITURE OF $25,492,788 ON A CASH BASIS FOR THE YEAR ENDED DECEMBER 31, 2019 EXCEEDED THE MRO REQUIREMENT OF $5,529,457 (3.5% OF PICI'S NON-RESEARCH ASSETS).ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$47,223OtherCostOrOtherBasisAmt
Book Value$47,223BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$673,048OtherCostOrOtherBasisAmt
Depreciation$298,342DepreciationAmt
Book Value$374,706BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$7,220,516OtherCostOrOtherBasisAmt
Depreciation$3,200,633DepreciationAmt
Book Value$4,019,883BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$4,441,812TotalBookValueLandBuildingsAmt

Invst Program Related Org InvstProgramRelatedOrgGrp (4 entries)

DescDescBook ValueBookValueAmtMethod ValuationMethodValuationCd
IMAGIN-AB (EQUITY INVESTMENT)$2,000,000F
TMUNITY (EQUITY INVESTMENT)$30,000,000F
LYELL IMMUNOPHARMA, INC. (EQUITY INVESTMENT)$19,999,999F
ARSENAL BIOSCIENCES, INC. (EQUITY INVESTMENT)$25,326,576F
FieldValueIRS element (for citing)
Total Book Value Program Rltd$77,326,575TotalBookValueProgramRltdAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$162,648,564TotalRevEtcAuditedFinclStmtAmt
Revenue Not Reported$0RevenueNotReportedAmt
Revenue Subtotal$162,648,564RevenueSubtotalAmt
Revenue Not Reported Fincl Stmt$0RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$162,648,564TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$77,964,615TotExpnsEtcAuditedFinclStmtAmt
Expenses Not Reported$0ExpensesNotReportedAmt
Expenses Subtotal$77,964,615ExpensesSubtotalAmt
Expenses Not Rpt Fincl Stmt$0ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$77,964,615TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART X, LINE 2:FormAndLineReferenceDesc
ExplanationPICI HAS NO UNRECOGNIZED TAX BENEFITS OR LIABILITIES AS OF DECEMBER 31, 2019 AND 2018.ExplanationTxt

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Agrmt Prof Fundraising ActyYes (1)AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp

Organization Business Name OrganizationBusinessName

FieldValueIRS element (for citing)
Business Name Line1TYGER PRODUCTIONSBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line150 TERMINAL STREET BLDG 1 UNIT 12AddressLine1Txt
CityBOSTONCityNm
State AbbreviationMAStateAbbreviationCd
ZIP02129ZIPCd
FieldValueIRS element (for citing)
ActivityPICI MSK GALAActivityTxt
Fundraiser Control Of Funds0FundraiserControlOfFundsInd
Gross Receipts$0GrossReceiptsAmt
Retained By Contractor$200,000RetainedByContractorAmt
Net To Organization$0NetToOrganizationAmt
FieldValueIRS element (for citing)
Total Retained By Contractors$200,000TotalRetainedByContractorsAmt
Licensed StatesCALicensedStatesCd

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (13 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER
1400 PRESSLER STREET FCT295223HOUSTONTX77030746001118GOVT$10,042,040SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
REGENTS OF UNIVERSITY OF CALIFORNIA SAN FRANCISCO
333 CALIFORNIA ST 315SAN FRANCISCOCA94143946036493GOVT$5,593,452SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
UNIVERSITY OF PENNSYLVANIA
3451 WALNUT STREETPHILADELPHIAPA19104231352685GOVT$5,452,600SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
MEMORIAL SLOAN KETTERING CANCER CENTER
1275 YORK AVE BOX 69NEW YORKNY10065912154267501(C)(3)$4,352,647SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
STANFORD UNIVERSITY
3145 PORTER DRIVEPALO ALTOCA94304941156365501(C)(3)$2,425,569SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
UNIVERSITY OF CALIFORNIA LOS ANGELES
10920 WILSHIRE BLVD STE 620LOS ANGELESCA90024956006143GOVT$2,260,431SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
DANA-FARBER CANCER INSTITUTE INC
450 BROOKLINE AVENUEBOSTONMA02115042263040501(C)(3)$1,083,332SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
CLINTON HEALTH ACCESS INITIATIVE INC
383 DORCHESTER AVENUEBOSTONMA02127271414646501(C)(3)$600,000SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
ICAHN SCHOOL OF MEDICINE
ONE GUSTAVE L LEVY PLACENEW YORKNY10029136171197501(C)(3)$577,612SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
WASHINGTON UNIVERSITY
700 ROSEDALE AVENUE CB 1034SAINT LOUISMO63112430653611501(C)(3)$549,473SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
INSTITUTE FOR SYSTEMS BIOLOGY
1801 LIND AVE SWRENTONWA980579016912003593501(C)(3)$547,922SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
FHCRC - HUTCHINSON
1100 FAIRVIEW AVE NSEATTLEWA98109237156071501(C)(3)$500,000SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
CITY OF HOPE
1500 E DUARTE RDDUARTECA91010953435919501(C)(3)$400,338SUPPORT RESEARCH IN FIELD OF CANCER IMMUNOTHERAPY
FieldValueIRS element (for citing)
Total501c3 Org13Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationPICI AWARDS GRANTS SUBJECT TO A MASTER COLLABORATION AGREEMENT AND A SPECIFIC GRANT AGREEMENT APPLICABLE TO EACH INSTITUTION.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Written Policy Ref T And E ExpnssYes (1)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (1)SubstantiationRequiredInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsYes (1)AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (8 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
RAMY IBRAHIM
CHIEF MEDICAL OFFICER$739,132$0$145,000$0$0$0$8,400$0$17,588$0$910,120$0$0$0
JEFFREY A BLUESTONE PHD
PRESIDENT/CEO & DIRECTOR$709,428$0$0$0$0$0$8,400$0$15,495$0$733,323$0$0$0
FREDERICK J RAMSDELL
CHIEF SCIENTIFIC OFFICER (THRU 12/19$396,341$0$35,719$0$0$0$8,400$0$17,823$0$458,283$0$0$0
THERESA LAVALLEE
VP-TRANSLATIONAL MEDICINE$383,059$0$33,696$0$0$0$8,400$0$26,080$0$451,235$0$0$0
NIKESH KOTECHA
VP-INFORMATICS$379,449$0$38,401$0$0$0$8,400$0$12,397$0$438,647$0$0$0
MELINDA GRIFFITH
CHIEF LEGAL COUNSEL, VP-ST$348,939$0$60,320$0$0$0$8,400$0$12,052$0$429,711$0$0$0
SUSAN SCHULTZ
VP-BUSINESS OPERATIONS$342,783$0$34,674$0$0$0$8,400$0$23,674$0$409,531$0$0$0
CHERYL SELINSKY PHD
VP-RESEARCH OPERATIONS$344,632$0$34,619$0$0$0$8,400$0$4,854$0$392,505$0$0$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART I, LINE 1AANYONE TRAVELING OVER 3000 MILES CAN FLY BUSINESS CLASS OR FIRST CLASS (IF ONLY 2 LEVELS OF SERVICE ARE OFFERED). VP'S CAN TRAVEL BUSINESS OR FIRST CLASS FOR TRAVEL OVER 2000 MILES.
PART I, LINE 3THE BOARD OF DIRECTORS OR EXECUTIVE COMMITTEE REVIEWS ANY PROPOSED COMPENSATION, INCLUDING THE SALARY, OF ITS CHIEF EXECUTIVE OFFICER TO ENSURE THAT, IN EACH CASE, SUCH SALARY IS FAIR AND REASONABLE BASED ON COMPARABILITY DATA SHOWING COMPENSATION PAID FOR COMPARABLE SERVICES AT SIMILARLY SITUATED ORGANIZATIONS.
PART I, LINE 7MOST OF PICI'S EMPLOYMENT AGREEMENTS, WHICH ARE NEGOTIATED AT ARMS-LENGTH WITH REFERENCE TO COMPARABILITY DATA, CONTAIN A PROVISION PERMITTING ANNUAL INCENTIVE BONUSES, WHICH ARE CAPPED AT UP TO A FIXED PERCENTAGE. THE CEO HAS NO SUCH INCENTIVE COMPENSATION, HOWEVER, AND IS PAID ON A FIXED SALARY.

Schedule L IRS990ScheduleL

Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp

FieldValueIRS element (for citing)
PersonRAMY IBRAHIMPersonNm
Relationship With OrgKEY EMPLOYEERelationshipWithOrgTxt
Loan PurposeRELOCATIONLoanPurposeTxt
Loan From OrganizationYes (X)LoanFromOrganizationInd
Original Principal$700,000OriginalPrincipalAmt
Balance Due$280,000BalanceDueAmt
Default0DefaultInd
Board Or Committee ApprovalYes (1)BoardOrCommitteeApprovalInd
Written AgreementYes (1)WrittenAgreementInd
FieldValueIRS element (for citing)
Total Balance Due$280,000TotalBalanceDueAmt

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution1ContributionCnt
Noncash Contributions Rpt F990$50,092,869NoncashContributionsRptF990Amt
Method Of Determining RevenuesFMVMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Form8283 Received0Form8283ReceivedCnt
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (1)ReviewProcessUnusualNCGiftsInd
Third Parties Used0ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, COLUMN (B):FormAndLineReferenceDesc
ExplanationTHE NUMBERS REPORTED IN PART I, COLUMN (B) REPRESENT THE NUMBER OF CONTRIBUTIONS.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (9 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 1THE BOARD OF DIRECTORS IS COMPRISED OF ONE 'CLASS A' DIRECTOR WITH THE BALANCE OF THE DIRECTORS SERVING AS 'CLASS B' DIRECTORS. THE CLASS A DIRECTOR MUST BE PRESENT TO CONSTITUTE A QUORUM, UNLESS THE CLASS A DIRECTOR'S RECUSAL IS REQUIRED BY LAW OR CORPORATE POLICY. EACH DIRECTOR IS ENTITLED TO ONE VOTE. ANY ACT OF THE BOARD OF DIRECTORS REQUIRES THE AFFIRMATIVE VOTE OF BOTH THE CLASS A DIRECTOR AND A MAJORITY OF THE CLASS B DIRECTORS PRESENT AT A MEETING AT WHICH A QUORUM IS PRESENT, EXCEPT AS OTHERWISE PROVIDED IN THE BYLAWS. PICI DOES HAVE AN EXECUTIVE COMMITTEE. IT HAS ALL THE AUTHORITY OF THE BOARD OF DIRECTORS BETWEEN REGULAR AND SPECIAL MEETINGS, EXCEPT AS OTHERWISE PROVIDED IN THE BYLAWS OR BY THE BOARD OF DIRECTORS IN SPECIFIC INSTANCES. ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO AND REVIEWED BY THE BOARD OF DIRECTORS AT ITS NEXT REGULARLY SCHEDULED MEETING.
FORM 990, PART VI, SECTION A, LINE 2THE FOLLOWING DIRECTORS AND OFFICERS HAVE A BUSINESS RELATIONSHIP: SEAN PARKER, BRUCE PARKER, MICHAEL POLANSKY, SUSAN DAWSON, TOM VAN LOBEN SELS, JEFFREY BLUESTONE, REED JOBS, BOB NELSEN, AND BEN HOROWITZ. THE FOLLOWING DIRECTORS HAVE A FAMILY RELATIONSHIP: SEAN PARKER AND BRUCE PARKER.
FORM 990, PART VI, SECTION A, LINE 4PICI AMENDED AND RESTATED ITS BYLAWS ON JUNE 5, 2019 AND OCTOBER 22, 2019. AMENDMENTS INCLUDE (A) APPOINTING A NEW DESIGNATOR, (B) CHANGING THE AUTHORIZED NUMBER OF DIRECTORS TO 1-25, (C) GIVING THE DESIGNATOR AUTHORITY TO SET THE AUTHORIZED NUMBER OF DIRECTORS WITHIN THAT RANGE, (D) ESTABLISHING TWO CLASSES OF DIRECTORS, CLASS A AND CLASS B, (E) ESTABLISHING A PROCEDURE TO DETERMINE WHICH DIRECTORS WILL SERVE ON THE EXECUTIVE COMMITTEE, AND (F) CLARIFYING HOW OFFICERS AND COMMITTEE MEMBERS ARE SELECTED.
FORM 990, PART VI, SECTION A, LINE 7ATHE DESIGNATOR HAS THE AUTHORITY TO APPOINT MEMBERS OF PICI'S GOVERNING BODY.
FORM 990, PART VI, SECTION A, LINE 7BTHE DESIGNATOR HAS THE AUTHORITY TO REMOVE MEMBERS OF PICI'S GOVERNING BODY, TO CONSENT TO SUCH REMOVAL BY THE BOARD, AND TO CONSENT TO ANY AMENDMENTS TO PICI'S BYLAWS.
FORM 990, PART VI, SECTION B, LINE 11BTHE FORM 990 IS REVIEWED BY THE AUDIT COMMITTEE. A COMPLETE COPY OF THE FORM 990 AND SUPPORTING SCHEDULES WAS PROVIDED TO THE FULL BOARD FOR REVIEW PRIOR TO BEING FILED.
FORM 990, PART VI, SECTION B, LINE 12CTHE BOARD AUTHORIZES AND OVERSEES A REVIEW OF THE ADMINISTRATION OF THE CONFLICT OF INTEREST POLICY. THE REVIEW CONSIDERS THE LEVEL OF COMPLIANCE WITH THE POLICY, THE CONTINUING SUITABILITY OF THE POLICY, AND WHETHER THE POLICY SHOULD BE MODIFIED AND IMPROVED. IF A TRANSACTION ARISES WHERE THERE IS A CONFLICT OF INTEREST, THE PERSON WITH SUCH CONFLICT IS NOT ALLOWED TO VOTE ON THE TRANSACTION NOR BE PRESENT FOR SUCH VOTE. THE CONFLICT OF INTEREST POLICY COVERS EACH DIRECTOR, CORPORATE OFFICER, TOP MANAGEMENT OFFICIAL, TOP FINANCIAL OFFICIAL AND EACH KEY EMPLOYEE OF PICI, AND OTHERS THAT PICI MAY IDENTIFY.
FORM 990, PART VI, SECTION B, LINE 15FORM 990, PART VI, SECTION B, LINE 15A - AS STATED AT SCHEDULE J, PART I, LINE 3, THE BOARD OF DIRECTORS APPROVED THE SALARY OF PICI'S CHIEF EXECUTIVE OFFICER ONLY AFTER HAVING CONFIRMED IT IS FAIR AND REASONABLE BASED ON COMPARABILITY DATA SHOWING COMPENSATION PAID FOR COMPARABLE SERVICES AT SIMILARLY SITUATED ORGANIZATIONS. THESE PROCEDURES WERE FOLLOWED WHEN THE CHIEF EXECUTIVE OFFICER'S SALARY WAS APPROVED BY THE BOARD OF DIRECTORS, WHICH DOES NOT INCLUDE THE CHIEF EXECUTIVE OFFICER, ON OCTOBER 30, 2017. SPECIFICALLY, THE BOARD OF DIRECTORS RELIED ON A COMPENSATION SURVEY AND FORM 990S OF SIMILAR ORGANIZATIONS. ANY FUTURE CHANGES TO THE COMPENSATION (INCLUDING ANY BONUSES PAID) OF THE CHIEF EXECUTIVE OFFICER WILL ONLY BE APPROVED BY THE BOARD OF DIRECTORS AFTER FOLLOWING THE PROCEDURES DESCRIBED ABOVE. FORM 990, PART VI, SECTION B, LINE 15B - IN GENERAL, PICI WORKED WITH A RECRUITER AND, AS PART OF THAT PROCESS, ROUTINELY COMPARED THE PROPOSED SALARY WITH SALARIES PAID BY OTHER ORGANIZATIONS FOR SIMILAR POSITIONS.
FORM 990, PART VI, SECTION C, LINE 19PICI'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE MADE AVAILABLE AS REQUIRED BY LAW.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (2 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdExempt Code SectionExemptCodeSectionTxtPublic Charity StatusPublicCharityStatusTxtDirect Controlling NADirectControllingNACdControlled OrganizationControlledOrganizationInd
SEAN N PARKER FOUNDATION
314 LYTTON AVEPALO ALTOCA94301274389819SUPPORTS NONPROFIT ORGANIZATIONSCA501(C)(3)PFN/A0
ECONOMIC INNOVATION GROUP INC
616 H STREET NW SUITE 550WASHINGTONDC20001462450336PUBLIC INTEREST ADVOCACYDC501(C)(4)N/AN/A0
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org0GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org0GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth OrgYes (1)LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of Facilities0SharingOfFacilitiesInd
Paid Employees Sharing0PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSCHEDULE R, SUPPLEMENTAL INFORMATION:FormAndLineReferenceDesc
ExplanationTHE CLASS A DIRECTOR ALSO HAS A CONTROLLING INTEREST IN SEVERAL PASSIVE INVESTMENT VEHICLES. THESE INVESTMENT VEHICLES AND THE TAX-EXEMPT ENTITIES DISCLOSED UNDER PART II ABOVE MAY TECHNICALLY BE CONSIDERED "RELATED ORGANIZATIONS" OF PICI FOR IRS FORM 990 REPORTING PURPOSES THROUGH THEIR RELATIONSHIP WITH THE CLASS A DIRECTOR. THE PASSIVE INVESTMENT VEHICLES HAVE NO TRANSACTIONS OR BUSINESS RELATIONSHIPS WITH PICI AND ARE NOT DISCLOSED ON SCHEDULE R.ExplanationTxt

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.